Fundraising Fox

Aclarion

NASDAQ: ACON

Broomfield, US · Founded 2015 · Delaware corporation

aclarion.com ↗

Aclarion develops NOCISCAN, a SaaS platform that uses MR spectroscopy to noninvasively help physicians distinguish painful from nonpainful spinal discs in patients with chronic low back pain. It complements conventional lumbar MRI with pain biomarker data and per-disc NOCI+/NOCI- scores to support treatment and surgical planning.

Digital HealthHealthtechMedical DevicesSaaS

Founders & leadership

Aclarion was founded in 2015 by Jeffrey Thramann.

JT
Jeffrey ThramannFounder
JL
John LorbieckiExecutive
BNBrent Ness
Brent NessExecutive
JC
James C Peacock IIINamed on SEC filing

Board

SD
Stephen DeitschBoard director
SB
Scott BreidbartBoard director
AW
Amanda WilliamsBoard director
WG
William Gerard WesemannBoard director
DN
David NealBoard director
RE
Robert EastlackBoard director
AD
Augustus DenisBoard director

Reported raises · per SEC filings

Form D private placements

$11.7M disclosed across 6 rounds · 2015–2024

▶$1MraisedOct 2024 · 3 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • John LorbieckiExecutive Officer
  • Stephen DeitschDirector
  • Scott BreidbartDirector
  • Amanda WilliamsDirector
  • William Gerard WesemannDirector
  • David NealDirector
  • Brent NessExecutive Officer, Director
  • Jeffrey ThramannExecutive Officer, Director
Offering amount
$1M
Amount sold
$1M
Minimum investment
$200K
First sale
Sep 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2MraisedMay 2023 · 2 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeffrey ThramannExecutive Officer, Director
  • John LorbieckiExecutive Officer
  • Brent NessExecutive Officer, Director
  • Amanda WilliamsDirector
  • David NealDirector
  • Stephen DeitschDirector
  • Scott BreidbartDirector
  • William Gerald WesemannDirector
Offering amount
$2M
Amount sold
$2M
Minimum investment
$289K
Sales commissions
$220K
Placement agents
Carter, Terry & Company, Inc, Maxim Group LLC
First sale
May 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2MraisedOct 2021 · 4 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • John LorbieckiExecutive Officer
  • Robert EastlackDirector
  • Brent NessExecutive Officer, Director
  • David K NealDirector
  • Lawrence TannenbaumDirector
  • Jeffrey ThramannDirector
  • William Gerard WesemannDirector
  • Jeffrey LotzDirector
Offering amount
$2M
Amount sold
$2M
Minimum investment
$30K
Sales commissions
$300K
Proceeds to insiders
$300K
Placement agents
Nocimed
First sale
Jun 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.4MraisedMar 2020 · 12 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Brett LanutiExecutive Officer, Director
  • Robert EastlackDirector
  • William Gerald WesemannDirector
  • Jeffrey LotzDirector
  • David K NealDirector
  • Michael HarshDirector
Offering amount
$2.5M
Amount sold
$1.4M
First sale
Feb 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.3MraisedMay 2018 · 14 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • James C Peacock IIIExecutive Officer, Director
  • William WesemannDirector
  • Brett LanutiExecutive Officer, Director
  • David NealDirector
  • Lothar KoobDirector
  • Robert EastlackDirector
Offering amount
$4M
Amount sold
$3.3M
First sale
Jul 2017
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2MraisedMar 2015 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert EastlackDirector
  • James C Peacock IIIExecutive Officer, Director
  • Augustus DenisDirector
Offering amount
$5M
Amount sold
$2M
Proceeds to insiders
$175K
First sale
Feb 2015
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 2

by search overlap
BirdEye17 shared keywordsBirdeye offers an AI-powered platform with multi-agent "AI Coworkers" that handle marketing, operations, and customer experience tasks such as search optimization, review generation, listings management, social posting, and front-desk coordination. It serves multi-location businesses, providing a unified view of customers, locations, and interactions.
Buoy Health15 shared keywordsBuoy Health offers an AI-based symptom checker that asks users questions to help identify possible health issues and guides them toward appropriate care, products, or providers. It also publishes health content reviewed by clinicians such as doctors, nurses, and therapists.

Companies competing with Aclarion for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Aclarion do?
Aclarion develops NOCISCAN, a SaaS platform that uses MR spectroscopy to noninvasively help physicians distinguish painful from nonpainful spinal discs in patients with chronic low back pain. It complements conventional lumbar MRI with pain biomarker data and per-disc NOCI+/NOCI- scores to support treatment and surgical planning.
Who founded Aclarion?
Aclarion was founded by Jeffrey Thramann in 2015.
How much funding has Aclarion raised?
Aclarion has disclosed $11.7M raised across 6 rounds.
Where is Aclarion headquartered?
Aclarion is headquartered in Broomfield, US.